This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot2: STU1 Ballot 2) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Generated Narrative: Composition 236538
version: 90; Last updated: 2025-03-25 23:23:30+0000
Profile: ComparativeEvidenceSynthesisReport
Artifact Description:
Example of ComparativeEvidenceSynthesisReport Profile
url: https://fevir.net/resources/Composition/236538
identifier: FEvIR Object Identifier/https://fevir.net/FOI/236538, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-comparative-evidence-report-85390-85789
status: Final
type: Comparative Evidence Synthesis Report
date: 2025-03-25 23:23:30+0000
author: Qiukui Hao
title: ComparativeEvidenceSynthesisReport: GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk
custodian: Computable Publishing LLC
Extension | Type |
Part Of | |
Cite As |